Understanding the factors associated with patients with dementia achieving their preferred place of death: a retrospective cohort study

Age and Ageing
Natasha WigginsKatherine E Sleeman

Abstract

dying in one's preferred place is a quality marker for end-of-life care. Little is known about preferred place of death, or the factors associated with achieving this, for people with dementia. to understand preferences for place of death among people with dementia; to identify factors associated with achieving these preferences. adults with a diagnosis of dementia who died between December 2015 and March 2017 and who were registered on Coordinate My Care, an Electronic Palliative Care Coordination System. retrospective cohort study. multivariable logistic regression investigated factors associated with achieving preferred place of death. we identified 1,047 people who died with dementia; information on preferred and actual place of death was available for 803. Preferred place of death was most commonly care home (58.8%, n = 472) or home (39.0%, n = 313). Overall 83.7% (n = 672) died in their preferred place. Dying in the preferred place was more likely for those most functionally impaired (OR 1.82 95% CI 1.06-3.13), and with a ceiling of treatment of 'symptomatic relief only' (OR 2.65, 95% CI 1.37-5.14). It was less likely for people with a primary diagnosis of cancer (OR 0.52, 95% CI 0.28-0.97), those who were 'for' cardio-pu...Continue Reading

References

Jan 14, 2000·BMJ : British Medical Journal·R Smith
Jan 28, 2005·Journal of the American Geriatrics Society·Susan L MitchellVincent Mor
Mar 25, 2008·Archives of Gerontology and Geriatrics·Miharu Nakanishi, Tatsuo Honda
Feb 2, 2010·Journal of Pain and Symptom Management·Christina L BellKamal H Masaki
Apr 20, 2010·Journal of the American Geriatrics Society·Dirk HouttekierLuc Deliens
Feb 22, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GomesUNKNOWN PRISMA
Feb 19, 2013·BMC Palliative Care·Barbara GomesIrene J Higginson
Jul 6, 2013·Palliative Medicine·Jenny T van der SteenUNKNOWN European Association for Palliative Care (EAPC)
Dec 20, 2014·International Journal of Palliative Nursing·Rebecca EvansDavid Oxenham
Oct 7, 2015·PLoS Medicine·Eric I BenchimolUNKNOWN RECORD Working Committee
Jan 23, 2016·The European Journal of General Practice·Ildikó GágyorJean-François Chenot
Aug 15, 2017·Annals of Internal Medicine·Thomas CallenderJoanne Droney
Aug 26, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Katherine E SleemanIrene J Higginson
Mar 8, 2018·Journal of the American Geriatrics Society·Simon N EtkindFliss E M Murtagh
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GomesUNKNOWN PRISMA

❮ Previous
Next ❯

Citations

Oct 15, 2019·Journal of the American Geriatrics Society·Sarah H CrossHaider J Warraich
Oct 17, 2019·Evidence-based Nursing·Jacqueline Reed
Aug 15, 2020·Frontiers in Psychiatry·Yvonne EisenmannKlaus Maria Perrar
Jan 22, 2021·Journal of the American Geriatrics Society·Natalie G RegierRebecca J Wright
Jun 5, 2021·Journal of the American Medical Directors Association·Jie Fu MasterJing Mao
Nov 25, 2021·Journal of Internal Medicine·Thomas Knight, Daniel Lasserson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.